Marc A. Iacobucci

Marc is a Managing Director of DFB and serves on the board and management team of Nanology LLC, a majority-owned company of DFB. He is part of a small team responsible for identifying new healthcare investment opportunities and leading them through development to value creation for DFB. He is currently involved in extensive preclinical and clinical oncology development programs for Nanology, which was formed in 2015. Prior to his current role, Marc led establishment of DFB-owned Phyton Biotech as a commercial operation.

Marc has been with DFB since 1993 with leadership roles in business development, marketing, project management, and operations across DFB's family of companies. Earlier in his career, Marc worked for Procter & Gamble as a market analyst, Merck as a pharmaceutical representative, and as a clinical pharmacist in Ohio and Texas. A graduate of the Ohio State University with a Bachelor of Science degree in Clinical Pharmacy, Marc received his Master of Business Administration from the University of Texas at Austin.